MSA Safety (MSA)
Bid | 170.71 |
Market Cap | 6.73B |
Revenue (ttm) | 1.83B |
Net Income (ttm) | 276.97M |
EPS (ttm) | 7 |
PE Ratio (ttm) | 24.54 |
Forward PE | 19.25 |
Analyst | Hold |
Ask | 172.62 |
Volume | 145,172 |
Avg. Volume (20D) | 220,714 |
Open | 170.51 |
Previous Close | 169.33 |
Day's Range | 170.29 - 173.19 |
52-Week Range | 127.86 - 187.41 |
Beta | 0.95 |
Analyst Forecast
According to 0 analyst ratings, the average rating for MSA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription

4 weeks ago · proactiveinvestors.com
Tiziana Life Sciences doses first MSA patient in new trial – ICYMITiziana Life Sciences Ltd (NASDAQ:TLSA) CEO Ivor Elrifi talked with Proactive about the company's latest milestone: dosing the first patient in its Phase 2a clinical trial targeting multiple system at...

4 weeks ago · proactiveinvestors.com
Tiziana Life Sciences doses first patient in Phase 2a MSA trialTiziana Life Sciences Ltd (NASDAQ:TLSA) announced that it has enrolled and dosed the first participant in its Phase 2a clinical trial evaluating intranasal foralumab in patients with Multiple System A...

1 month ago · seekingalpha.com
MSA Safety Incorporated (MSA) Q2 2025 Earnings Conference Call TranscriptMSA Safety Incorporated (NYSE:MSA ) Q2 2025 Earnings Call August 5, 2025 10:00 AM ET Company Participants Elyse L. Brody - Interim Chief Financial Officer Lawrence Tighe De Maria - Executive Director ...

1 month ago · fool.com
MSA (MSA) Earnings Beat EstimatesMSA (MSA) Earnings Beat Estimates